Aims and Scope
The British Journal of Haematology is a peer-reviewed medical journal focusing on hematology and other blood-related topics, such as blood diseases and their treatment. It is published by Wiley-Blackwell on behalf of the British Society for Haematology.
Key Metrics
7.4
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.01 - 0.05
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.86
5-Year SI
5-year SI
- 0.88 2-year SI
- 0.84 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Hematology
SJR
- Q1 Hematology
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.66
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
3 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
45%
4 to 6 months
47%
7 to 9 months
6%
Above 9 months
2%
Did you find this useful?
Thank you for your feedback.
Topics Covered
- Lymphoma
- Heparin
- Overall survival
- Immune thrombocytopenia
- Diffuse large B-cell lymphoma
- Gene expression
- Hematopoietic stem cell transplantation
- Anticoagulant
- Lymphoblastic Leukemia
- Immunotherapy
- Central nervous system
- Aplastic anemia
- Arsenic
- Bortezomib
- Cancer
- Dexamethasone
- Imatinib
- Reactive oxygen species
- B-cell lymphoma
- Rituximab
Journal Specifications
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 1955 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in British Journal of Haematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Somatic co‐alteration signatures are prognostic in high‐grade <scp><i>TP53</i></scp>‐mutated myeloid neoplasms
- 17 Nov 24
- British Journal of Haematology
-
Full paper
Dutcher bodies and Russell bodies in a case of t(11;14) multiple myeloma.
- 14 Nov 24
- British journal of haematology
-
Full paper
Clonal haemopoiesis and venous thromboembolism risk.
- 14 Nov 24
- British journal of haematology
-
Full paper
M-protein-related necrobiotic granuloma in a multiple myeloma patient treated with daratumumab, lenalidomide and dexamethasone.
- 14 Nov 24
- British journal of haematology
-
Full paper
Dissecting the genomic traits and clinical course of secondary myelodysplastic syndrome following aplastic anaemia: A milestone.
- 14 Nov 24
- British journal of haematology
-
Full paper
Clinical and neurophysiological aspects of peripheral neuropathy in patients with myelodysplastic syndromes.
- 14 Nov 24
- British journal of haematology
Scite analysis
Powered by scite_
28.5k articles received 602.7k citations see all
- 28,123 Supporting
- 552,526 Mentioning
- 5,137 Contrasting
Editorial notices
- 6 Retractions
- 0 Withdrawals
- 44 Corrections
- 135 Errata
- 1 Expression of Concern
FAQs
How long has British Journal of Haematology been actively publishing?
British Journal of Haematology has been in operation since 1955 till date.
What is the publishing frequency of British Journal of Haematology ?
British Journal of Haematology published with a Semi-monthly frequency.
How many articles did British Journal of Haematology publish last years ?
In 2023, British Journal of Haematology published 674 articles.
What is the eISSN & pISSN for British Journal of Haematology ?
For British Journal of Haematology,eISSN is 1365-2141 and pISSN is0007-1048.
What is Citescore for British Journal of Haematology ?
Citescore for British Journal of Haematology is 7.4.
What is SNIP score for British Journal of Haematology ?
SNIP score for British Journal of Haematology is 1.66.
What is the SJR for British Journal of Haematology ?
SJR for British Journal of Haematology is Q1.
Who is the publisher of British Journal of Haematology ?
WILEY is the publisher of British Journal of Haematology.